WOLVERINE ASSET MANAGEMENT LLC - MERRIMACK PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
WOLVERINE ASSET MANAGEMENT LLC ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2017$34,000
-89.1%
27,500
-72.9%
0.00%
-100.0%
Q1 2017$312,000
+47.9%
101,400
+95.4%
0.01%
+66.7%
Q4 2016$211,000
+229.7%
51,900
+408.8%
0.00%
+200.0%
Q3 2016$64,000
+1500.0%
10,200
+18114.3%
0.00%
Q3 2015$4,000
-85.7%
56
-90.7%
0.00%
-100.0%
Q1 2015$28,000
-65.9%
600
-14.3%
0.00%
-50.0%
Q4 2014$82,000
+67.3%
700
-59.4%
0.00%
+100.0%
Q3 2014$49,000
-76.7%
1,724
-46.9%
0.00%
-80.0%
Q2 2014$210,000
+36.4%
3,248
-35.7%
0.01%
+66.7%
Q1 2014$154,000
+51.0%
5,053
+823.8%
0.00%
+50.0%
Q4 2013$102,000547
+2504.8%
0.00%
Q3 2013$0210.00%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
Lagoda Investment Management, L.P. 2,100,140$25,968,0006.81%
Portolan Capital Management 664,298$8,214,0001.15%
GARRISON BRADFORD & ASSOCIATES INC 90,700$1,122,0001.10%
Opus Point Partners Management, LLC 72,009$890,0000.70%
Eagle Ridge Investment Management 122,500$1,515,0000.68%
EAM Investors, LLC 350,410$4,333,0000.51%
WESTFIELD CAPITAL MANAGEMENT CO LP 4,881,667$60,362,0000.37%
Cannell & Co. 1,051,178$12,998,0000.37%
Birchview Capital, LP 42,300$523,0000.28%
Tekla Capital Management LLC 567,787$7,021,0000.25%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders